RESUMO
Scientific advances are continually improving the knowledge of acne and contributing to the refinement of treatment options; it is important for clinicians to regularly update their practice patterns to reflect current standards. The Global Alliance to Improve Outcomes in Acne is an international group of dermatologists with an interest in acne research and education that has been meeting regularly since 2001. As a group, we have continuously evaluated the literature on acne. This supplement focuses on providing relevant clinical guidance to health care practitioners managing patients with acne, with an emphasis on areas where the evidence base may be sparse or need interpretation for daily practice.
Assuntos
Acne Vulgar/tratamento farmacológico , Dermatologistas/normas , Gerenciamento Clínico , Guias de Prática Clínica como Assunto , Acne Vulgar/diagnóstico , Administração Oral , Administração Tópica , Antibacterianos/administração & dosagem , Consenso , Quimioterapia Combinada , Feminino , Humanos , Internacionalidade , Masculino , Melhoria de Qualidade , Retinoides/uso terapêutico , Medição de Risco , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
Propionibacterium acnes (P. acnes) and Propionibacterium granulosum (P. granulosum) are common skin colonizers that are implicated as possible contributing factors in acne vulgaris development. We have established direct visualization tools for the simultaneous detection of these closely related species with immunofluorescence assay and fluorescence in situ hybridization (FISH). As proof of principle, we were able to distinguish P. acnes and P. granulosum bacteria in multi-species populations in vitro as well as in a mock skin infection model upon labelling with 16S rRNA probes in combinatorial FISH as well as with antibodies. Furthermore, we report the co-localization of P. acnes and P. granulosum in the stratum corneum and hair follicles from patients with acne vulgaris as well as in healthy individuals. Further studies on the spatial distribution of these bacteria in skin structures in various skin disorders are needed.
Assuntos
Acne Vulgar/microbiologia , Imunofluorescência/métodos , Hibridização in Situ Fluorescente , Propionibacterium/classificação , Propionibacterium/genética , Folículo Piloso/microbiologia , Humanos , Pele/microbiologiaAssuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/administração & dosagem , Farmacorresistência Bacteriana , Propionibacterium acnes/efeitos dos fármacos , Acne Vulgar/diagnóstico , Acne Vulgar/genética , Acne Vulgar/patologia , Adolescente , Adulto , Peróxido de Benzoíla/administração & dosagem , Fármacos Dermatológicos/administração & dosagem , Prescrições de Medicamentos/estatística & dados numéricos , Farmacorresistência Bacteriana/genética , Farmacorresistência Bacteriana/fisiologia , Quimioterapia Combinada , Uso de Medicamentos , Feminino , Humanos , Masculino , Guias de Prática Clínica como Assunto , Propionibacterium acnes/genética , Tetraciclina/administração & dosagemRESUMO
Acne vulgaris is a chronic inflammatory condition of the pilosebaceous units. Antibiotics are widely used in acne therapy and can be administrated topically or systemically. The main negative effect of antibiotic treatment is bacterial resistance to antibiotics.
Assuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/uso terapêutico , Acne Vulgar/fisiopatologia , Administração Oral , Administração Tópica , Quimioterapia Combinada , HumanosRESUMO
The aim of this study was to compare the clinical and microbiological effect on Propionibacterium acnes of oral tetracycline plus topical adapalene vs. oral isotretinoin in moderate to severe acne vulgaris. Male and female acne patients with moderate or severe inflammatory disease were enrolled and assigned randomly to 6 months of treatment with oral tetracycline hydrochloride plus topical adapalene, or oral isotretinoin, in a controlled, open study. After cessation of oral treatment the antibiotic-treated group received topical adapalene for the 2-month follow-up period. Clinical and microbiological assessments were performed. Skin samples for microbial identification and quantification were taken at baseline, after 2, 4 and 6 months of treatment, and 2 months after cessation of treatment. Patients treated with isotretinoin showed prolonged significant remission compared with the other group. The density of resistant propionibacteria did not change significantly in any of the groups and there was no correlation between resistant P. acnes and the clinical response in any of the regions investigated. Antibiotic treatment was found to be a good alternative to isotretinoin, regardless of the presence of antibiotic-resistant P. acnes, although isotretinoin had a better effect, with prolonged remission after treatment.
Assuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Isotretinoína/uso terapêutico , Tetraciclina/uso terapêutico , Acne Vulgar/microbiologia , Adapaleno , Administração Oral , Administração Tópica , Adolescente , Adulto , Antibacterianos/farmacologia , Clindamicina/farmacologia , Farmacorresistência Bacteriana , Quimioterapia Combinada , Feminino , Humanos , Masculino , Naftalenos/uso terapêutico , Qualidade de Vida , Indução de Remissão , Fatores Sexuais , Resultado do TratamentoRESUMO
The purpose of the study was to characterize the resistance mechanism of 36 clindamycin (CL) and erythromycin (EM) resistant Propionibacterium acnes strains and 27 tetracycline (TET) resistant P. acnes isolates, collected from nine European countries, both from acne patients and from patients with different infections. PCR and sequencing of the genes encoding domain V of 23S rRNA for CL and EM resistant strains and 16S rRNA for TET resistant strains were performed. Pulsed-field gel electrophoresis was used as a typing method to establish the relationship between resistance genotypes and pulsed-field types. Several unique resistant genotypes were found to be distributed throughout Europe. P. acnes CL and EM resistant strains carrying one of the mutations within the 23S rRNA were predominantly isolated from Swedish acne patients (64%) compared to other infections (43%), OR=2.33 [CI=1.16-4.69]. Of 36 P. acnes isolates tested, none was found to carry the erm(X) resistance gene. Forty-four percent of TET resistant strains were found to carry a G-C transition in the 16S rRNA of the small ribosomal subunit and all these strains were isolated from Swedish acne patients. MIC of TET among all strains carrying this G-C mutation (n=12) was 32 mg/L and the MIC range for the strains where no mutation was detected ranged from 2 to 8 mg/L. The MIC values of TET were unaffected by the presence of reserpine, a well-known inhibitor of efflux pumps. Those TET resistant strains harbouring the mutation at 16S rRNA were clustered in one pulsotype. For TET resistant strains where no mutation was found, greater variability was noticed. No correlation was noticed between different resistance genotypes of CL and EM resistant strains and pulsed-field types.
RESUMO
The objective was to study the prevalence and antibiotic susceptibility patterns of Propionibacterium acnes strains isolated from patients with moderate to severe acne in Stockholm, Sweden and to determine the diversity of pulsed-field gel electrophoresis types among resistant P. acnes strains. One hundred antibiotic-treated patients and 30 non-antibiotic-treated patients with moderate to severe acne participated in the investigation. Facial, neck and trunk skin samples were taken with the agar gel technique. The susceptibility of P. acnes strains to tetracycline, erythromycin, clindamycin and trimethoprim-sulfamethoxazole was determined by the agar dilution method. The genomic profiles of the resistant strains were determined by pulsed-field gel electrophoresis. In the group of patients treated with antibiotics, resistant P. acnes strains were recovered in 37%, while in the non-antibiotic group of patients the incidence of resistant strains was 13%. Thus antibiotic-resistant P. acnes strains were significantly more often isolated from antibiotic-treated patients with moderate to severe acne than from non-antibiotic-treated patients (odds ratio, 3.8; P=0.01). There was a genetic diversity among the P. acnes strains. Forty-four different patterns of SpeI DNA digests were detected and two predominant clones were found. P. acnes strains exhibited different antibiotic susceptibility patterns and identical genotypes or vice versa. A person can be colonized with different strains with varying degrees of antibiotic resistance. The risk of increased resistance of P. acnes must be considered when treating acne patients with antibiotics, and especially long-term therapy should be avoided.